Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Molecular precision medicine in pancreatic cancer: A single-center experience.
Authors
Anthony Tarabay
Gustave Roussy Cancer Campus, Villejuif, France
Anthony Tarabay , Antoine Hollebecque , Cristina Smolenschi , Leony Antoun , Caroline Klotz , Alina Fuerea , Audrey Perret , Claire Gouriou , Pascal Burtin , Hichem Belkhodja , Valérie Boige , David Malka , Michel Ducreux
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
DOI
10.1200/JCO.2022.40.4_suppl.605
Abstract #
605
Poster Bd #
L2
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Comprehensive molecular profiling of paired patient samples of primary and metastatic (met) pancreatic ductal adenocarcinoma (PDAC).
First Author: Neel Trivedi
Poster
2024 ASCO Gastrointestinal Cancers Symposium
New cutoff of CA19-9 values for predicting pancreatic cancer using liquid biopsy.
First Author: Ryuji Hasebe
Poster
2023 ASCO Annual Meeting
Molecular and clinical correlates of DSCR1 expression in pancreatic cancer (PDAC).
First Author: Francesca Battaglin
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Impact of KRAS mutation variants on clinicopathological features and outcomes in patients with metastatic pancreatic adenocarcinoma.
First Author: Chirag Patel